An update on the molecular actions of fenofibrate and its clinical...
An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes.
Fenofibrate induces apoptosis of triple-negative breast cancer cells...
There are a lot of unmet needs in patients with triple-negative breast cancer . Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, has been used for decades to treat hypertriglyceridaemia and mixed dyslipidaemia.
Findings in the Area of Chemical Engineering Reported from New Jersey Institute of Technology
Sonication energy enables forming nanosized melt droplets, and nanosized solid particles upon subsequent cooling."
Hereditary features, treatment, and prognosis of the lipoprotein...
Correspondence: Zhangxue Hu, Department of Nephrology, and Yuan Yang, Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
AbbVie profit falls but calls hepatitis C drug results promising
AbbVie +3.5% in early trading despite reporting a 27% Y/Y drop in Q4 earnings , as the company releases positive results on its final-phase clinical trials for a promising new drug to treat certain patients with hepatitis C. ABBV's blockbuster drug Humira eclipsed $10B in sales in 2013, making it the highest-grossing drug in the world; sales of the ... (more)